The Nutritional Outlook Podcast Episode 9: What does new FDA leadership mean for the dietary supplement industry?
In this episode, the Nutritional Outlook editors interview Robert Durkin, Of Counsel, for Arnall Golden Gregory LLP’s FDA and Healthcare practices. Previously, Durkin worked as the acting director and deputy director of the Office of Dietary Supplement Programs, in the FDA’s Center for Food Safety and Applied Nutrition. Given Durkin’s experience at FDA, he is well-qualified to provide some insights into how the leadership of FDA’s recently confirmed commissioner Robert Califf, MD, may affect the dietary supplement industry.
Robert Durkin, Of Counsel, for Arnall Golden Gregory LLP.
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
